Faculty of Health Sciences, Curtin University, Bentley, WA, Australia.
Xiangya School of Public Health, Central South University, Changsha, China.
Trop Med Int Health. 2022 Mar;27(3):290-299. doi: 10.1111/tmi.13720. Epub 2022 Feb 6.
Globally, China has the third highest number of tuberculosis (TB) cases despite high rates (85.6%) of effective treatment coverage. Identifying risk factors associated with unsuccessful treatment outcomes is an important component of maximising the efficacy of TB control programmes.
Retrospective cohort study to evaluate the outcomes of 306,860 drug-susceptible TB patients who underwent treatment in Hunan Province, China between 2013 and 2018. Univariable and multivariable logistic regression models were used to identify factors associated with unsuccessful TB treatment outcomes.
A successful treatment outcome was recorded for 98.6% of patients, defined as the sum of patients who were cured (36.2%) and completed treatment (62.4%). An unsuccessful treatment outcome was recorded for 1.8% of patients, defined as the sum of treatment failure (1.1%), deaths (0.5%) and lost to follow up (0.2%). The odds of an unsuccessful treatment outcome showed an increasing trend in more recent years of registration (2018 adjusted odds ratio (AOR): 1.43; 95% Confidence Interval (CI) 1.31, 1.57 relative to 2013). Other significant risk factors were male sex (AOR: 1.17; 95% CI 1.10, 1.25); increasing age (AOR:1.02 per year increase; 95% CI 1.02,1.02); being severely ill (AOR: 1.50; 95% CI 1.33, 1.70); having a history of TB treatment (AOR: 2.93; 95% CI 2.69, 3.20); not being under systematic management (AOR: 16.10 (14.49, 17.88) and treatment regimens that differed from full course management.
The increasing likelihood of an unsuccessful treatment outcome over time necessitates the need for further research.
尽管中国的结核病(TB)治疗覆盖率高达 85.6%,但中国的结核病病例数在全球仍位居第三。确定与治疗结果不理想相关的风险因素是最大限度提高结核病控制规划疗效的重要组成部分。
对 2013 年至 2018 年期间在中国湖南省接受治疗的 306860 例药物敏感结核病患者的治疗结果进行回顾性队列研究。采用单变量和多变量逻辑回归模型确定与结核病治疗结果不理想相关的因素。
98.6%的患者治疗结果成功,定义为治愈(36.2%)和完成治疗(62.4%)的患者总和。1.8%的患者治疗结果不理想,定义为治疗失败(1.1%)、死亡(0.5%)和失访(0.2%)的患者总和。登记时间较晚的患者,其治疗结果不理想的可能性呈上升趋势(2018 年调整比值比(AOR):1.43;95%置信区间(CI)1.31,1.57,与 2013 年相比)。其他显著的风险因素包括男性(AOR:1.17;95%CI 1.10,1.25);年龄增长(AOR:每年增加 1.02;95%CI 1.02,1.02);病情严重(AOR:1.50;95%CI 1.33,1.70);有结核病治疗史(AOR:2.93;95%CI 2.69,3.20);未接受系统管理(AOR:16.10(14.49,17.88)和治疗方案与全程管理不同。
随着时间的推移,治疗结果不理想的可能性不断增加,因此需要进一步研究。